Tech·SOURCE: Ars Technica·Nov 11, 2026
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
01 · EXECUTIVE SUMMARY & CONTEXT
The risk appears small and data is mixed, but FDA wants patients to be aware.
03 · THE IN-DEPTH ANALYSIS
The risk appears small and data is mixed, but FDA wants patients to be aware.